Scilex Holding Co. (SCLX)
5.495
+0.06
(+1.20%)
USD |
NASDAQ |
Aug 31, 16:00
5.59
+0.10
(+1.73%)
After-Hours: 06:41
Scilex Debt to Equity Ratio : -0.3437 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3437 |
| March 31, 2026 | -0.4268 |
| December 31, 2025 | -0.6379 |
| September 30, 2025 | -0.3824 |
| June 30, 2025 | -0.1983 |
| March 31, 2025 | -0.2308 |
| December 31, 2024 | -0.2323 |
| September 30, 2024 | -0.4797 |
| June 30, 2024 | -0.4984 |
| March 31, 2024 | -0.5904 |
| December 31, 2023 | -0.7428 |
| September 30, 2023 | -0.7705 |
| Date | Value |
|---|---|
| June 30, 2023 | 3.622 |
| March 31, 2023 | 0.1114 |
| December 31, 2022 | 0.0389 |
| September 30, 2022 | 0.0561 |
| June 30, 2022 | 0.0451 |
| March 31, 2022 | 0.0156 |
| December 31, 2021 | -0.6912 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 6.684 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Oramed Pharmaceuticals, Inc. | 0.0023 |
| Semnur Pharmaceuticals, Inc. | -0.7768 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 253.56M |
| Total Liabilities (Quarterly) | 564.05M |
| Shareholders Equity (Quarterly) | -308.32M |
| Current Ratio | 0.0707 |
| Net Debt Paydown Yield | -20.84% |